The new test is compatible with Roche's cobas 5800, 6800, and 8800 molecular diagnostic analysers, which are widely used in hospitals and other clinical settings, without any need for upgrades.

Roche (OTCQX:RHHBY) has received FDA clearance with a CLIA waiver for its cobas liat sexually transmitted infection, or STI, multiplex assay panels. The tests will be available exclusively in the U.S.

Roche has received the CE mark certification ... of up to 15 targets in a single patient sample on the cobas 5800, 6800, and 8800 molecular diagnostic analyser systems. It is designed to ...